scholarly journals Author’s Reply: Recently introduced thrombolytic therapy regimens have been sufficiently effective and safer in patients with prosthetic valve thrombosis

2019 ◽  
Vol 19 (2) ◽  
pp. 75
Author(s):  
Diego Araiza-Garaygordobil
2019 ◽  
Vol 10 (6) ◽  
pp. 345-349 ◽  
Author(s):  
Akshyaya Pradhan ◽  
Monika Bhandari ◽  
Vikas Gupta ◽  
Pravesh Vishwakarma ◽  
Rishi Sethi ◽  
...  

2020 ◽  
Vol 7 (5) ◽  
pp. 853
Author(s):  
Santhosh Jadhav ◽  
H. S. Natraj Setty ◽  
Shankar S. ◽  
Phani Teja Mundru ◽  
Yeriswamy M. C. ◽  
...  

Pregnancy with mechanical valves requires anticoagulation, the risk of bleeding and embryopathy associated with oral anticoagulation must be weighed against the risk of valve thrombosis. In the presence of a mechanical valve thrombosis, an appropriate treatment modality must be selected. Prosthetic valve thrombosis during pregnancy requires immediate therapy such as valve replacement, thrombolytic therapy, or surgical thrombectomy. A course of thrombolytic therapy may be considered as a first-line therapy for prosthetic heart valve thrombosis. We describe a primigravida (second trimester) with mitral valve replacement status presenting with acute prosthetic valve thrombosis and treated successfully with intravenous streptokinase.


2017 ◽  
Vol 69 ◽  
pp. S6 ◽  
Author(s):  
B. Midhun Kumar ◽  
G. Justin Paul ◽  
N. Swaminathan ◽  
G. Gnanavelu ◽  
G. Ravishankar ◽  
...  

2010 ◽  
Vol 17 (5) ◽  
pp. 387-393 ◽  
Author(s):  
Horacio Pérez López ◽  
Fidel Manuel Cáceres Lóriga ◽  
Karel Morlans Hernàndez ◽  
Humberto Fagundo Sánchez ◽  
Noel González Jimenez ◽  
...  

2020 ◽  
Vol 29 (3) ◽  
pp. e29-e30
Author(s):  
Ahmet Guner ◽  
Macit Kalcik ◽  
Sabahattin Gunduz ◽  
Semih Kalkan ◽  
Mustafa Ozan Gursoy ◽  
...  

1992 ◽  
Vol 123 (6) ◽  
pp. 1575-1580 ◽  
Author(s):  
Ramachandran S. Vasan ◽  
Upendra Kaul ◽  
Sanjeev Sanghvi ◽  
T. Kamlakar ◽  
Prakash C. Negi ◽  
...  

2015 ◽  
Vol 66 (7) ◽  
pp. 875-876 ◽  
Author(s):  
Sabahattin Gündüz ◽  
Mahmut Yesin ◽  
Mustafa Ozan Gürsoy ◽  
Macit Kalçık ◽  
Mehmet Özkan

2021 ◽  
Vol 10 (14) ◽  
pp. 1035-1038
Author(s):  
Ayan Husain ◽  
Shilpa Abhay Gaidhane ◽  
Priti Abhay Karadbhajane ◽  
Sourya Acharya ◽  
Apoorva Nirmal

Prosthetic cardiac valve thrombosis is a rare but dangerous complication; 1,2 particularly in patients with low conformity on anticoagulant therapy. Thromboembolic problems happen after mechanical valve substitution in 0.5 - 8 percent. 3-5 Fibrinolytic therapy to treat the thrombosis is widely used nowadays with high efficacy and no severe side effects as compared to emergency surgical treatment, which is associated with high mortality.6 Surgical valve repair in patients with rheumatic heart disease remains the gold standard for the treatment. Thrombosis of the prosthetic heart valve in patients undergoing valve replacement, is the most severe and deadly complication. Currently, the treatments available for symptomatic prosthetic valve thrombosis are immediate surgery or thrombolytic therapy (TT). In rural hospital settings patients are poor and there is a lack of surgical expertise. These factors make TT the perfect treatment for prosthetic valve thrombosis. But one should be aware of embolic complications.


Sign in / Sign up

Export Citation Format

Share Document